Details for Patent: 10,188,811
✉ Email this page to a colleague
Which drugs does patent 10,188,811 protect, and when does it expire?
Patent 10,188,811 protects QNASL and is included in one NDA.
This patent has forty-five patent family members in twenty-nine countries.
Summary for Patent: 10,188,811
| Title: | Nasal spray device |
| Abstract: | A nasal spray device for the delivery of a pharmaceutical formulation to the nasal cavity in metered doses. The device includes: a pressurised aerosol canister including a vial containing a pharmaceutical formulation including an active ingredient, a propellant and, optionally, a co-solvent, the aerosol canister further including a metering valve having a valve stem; and an actuator for the aerosol canister, the actuator including a stem block having a receptacle into which the valve stem of metering valve of the aerosol canister is received and axially located and being displaceable relative to the vial of the aerosol canister to actuate the metering valve of the aerosol canister, a sump extending below the receptacle, the stem block further defining a discharge orifice for the pharmaceutical formulation and a transfer channel through which a dispensed dose of the pharmaceutical formulation is able to pass from the sump to the discharge orifice. |
| Inventor(s): | Zeng; Xian-Ming (Miami, FL), Walsh; Declan (Co. Kilkenny, IE), Ly; Jade Ching-Ying (Miami, FL), Morales; Armando (Miami, FL) |
| Assignee: | TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (Horsham, PA) IVAX PHARMACEUTICALS IRELAND (Waterford, IE) |
| Application Number: | 14/865,823 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; Device; |
Drugs Protected by US Patent 10,188,811
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | QNASL | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 202813-002 | Dec 17, 2014 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Teva Branded Pharm | QNASL | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 202813-001 | Mar 23, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,188,811
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011316124 | ⤷ Try a Trial | |||
| Brazil | 112013008824 | ⤷ Try a Trial | |||
| Canada | 2814212 | ⤷ Try a Trial | |||
| Chile | 2013000958 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
